European Foundation for the Study of Chronic Liver Failure (Ef-Clif)

Where the EU money came from

Funding by EU programme. Amounts are European Foundation for the Study of Chronic Liver Failure (Ef-Clif)'s own share of each project, not the project's full budget.

Projects

9 EU-funded projects, newest first. European Foundation for the Study of Chronic Liver Failure (Ef-Clif) led 3 of them as coordinator. Each links to the official record.

• DYNAMISAssociated partner

  IDIBAPS Doctoral programme Yielding Novel Advancements in Medicine and Innovative Solutions

  Horizon Europe · 2026–2030 · Project on CORDIS ↗
• LEOPARDPartner

  Liver Electronic Offering Platform with Artificial intelligence-based Devices

  Horizon Europe · 2023–2028 · Project on CORDIS ↗

  €260ktheir share
• IHMCSAPartner

  International Human Microbiome Coordination and Support Action

  Horizon 2020 · 2021–2024 · Project on CORDIS ↗

  €131ktheir share
• A-TANGOCoordinator

  NOVEL TREATMENT OF ACUTE ON CHRONIC LIVER FAILURE USING SYNERGISTIC ACTION OF G-CSF AND TAK-242

  Horizon 2020 · 2021–2026 · Project on CORDIS ↗

  €424ktheir share
• DECISIONCoordinator

  DECOMPENSATED CIRRHOSIS: IDENTIFICATION OF NEW COMBINATORIAL THERAPIES BASED ON SYSTEMS APPROACHES

  Horizon 2020 · 2020–2026 · Project on CORDIS ↗

  €1.3Mtheir share
• MICROB-PREDICTCoordinator

  MICROBiome-based biomarkers to PREDICT decompensation of liver cirrhosis and treatment response

  Horizon 2020 · 2019–2026 · Project on CORDIS ↗

  €2.3Mtheir share
• LIVERHOPEPartner

  SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS

  Horizon 2020 · 2017–2023 · Project on CORDIS ↗

  €50ktheir share
• ALIVERPartner

  Development of DIALIVE, a novel Liver Dialysis Device for the treatment of patients with Acute on Chronic Liver Failure (ACLF)

  Horizon 2020 · 2017–2021 · Project on CORDIS ↗

  €121ktheir share
• CARBALIVEPartner

  Clinical evaluation of carbons of controlled porosity as a new therapeutic for the treatment of liver cirrhosis and non-alcoholic fatty liver disease.

  Horizon 2020 · 2015–2021 · Project on CORDIS ↗

  €83ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• University College LondonUnited Kingdom · 6 shared projects
• Assistance Publique Hopitaux de ParisFrance · 6 shared projects
• Fundacio de Recerca Clinic Barcelona-Institut D Investigacions Biomediques August Pi i SunyerSpain · 5 shared projects
• Hospital Clinic de BarcelonaSpain · 5 shared projects
• European Liver Patients AssociationBelgium · 5 shared projects
• European Association for the Studyof the LiverSwitzerland · 5 shared projects
• Alma Mater Studiorum - Universita di BolognaItaly · 3 shared projects
• Universita Degli Studi di PadovaItaly · 3 shared projects
• Universitat de BarcelonaSpain · 3 shared projects
• Johann Wolfgang Goethe-Universitaet Frankfurt am MainGermany · 3 shared projects
• Servicio Madrileno de SaludSpain · 3 shared projects
• Universite Paris CiteFrance · 3 shared projects
• Concentris Research Management GmbHGermany · 3 shared projects
• Yaqrit LimitedUnited Kingdom · 3 shared projects
• Commissariat A L Energie Atomique et aux Energies AlternativesFrance · 2 shared projects
• Katholieke Universiteit LeuvenBelgium · 2 shared projects

Fields it works in

Research fields recorded on its Horizon projects.

• antibiotics
• hepatology
• infectious diseases
• microbiology
• mortality
• nutrition
• obesity
• pathophysiology
• productivity
• proteins
• transplantation